Related Experiment Video

Updated: Jul 5, 2026

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

Taming the PI3K team to hold inflammation and cancer at bay

Emilio Hirsch1, Elisa Ciraolo, Alessandra Ghigo

  • 1Molecular Biotechnology Center, University of Torino, via Nizza 52, 10126 Torino, Italy. emilio.hirsch@unito.it

Pharmacology & Therapeutics
|April 19, 2008
PubMed

Insights

Researchers are exploring phosphoinositide 3-kinase (PI3K) pathways as drug targets. Targeting these common signal transduction platforms offers new therapeutic strategies for inflammation and cancer.

Area of Science:

  • Molecular Biology
  • Pharmacology
  • Biochemistry

Background:

  • Receptor signal transduction offers novel drug targets for unmet medical needs.
  • Common signal transduction pathways across receptor families enable new therapeutic strategies.
  • Phosphoinositide 3-kinases (PI3Ks) are key downstream effectors of multiple cellular responses.

Purpose of the Study:

  • To review recent advances in understanding PI3K signaling.
  • To highlight the role of PI3Ks in cellular processes like proliferation, survival, immunity, and cardiovascular control.
  • To discuss ongoing efforts in developing PI3K inhibitors for therapeutic applications.

Main Methods:

  • Literature review of recent research on PI3K signaling pathways.
  • Analysis of studies validating PI3K family members as drug targets.
  • Examination of therapeutic strategies targeting PI3Ks for inflammatory and cancerous diseases.

Main Results:

  • PI3Ks play a critical role in regulating diverse cellular functions.
  • Targeting PI3Ks presents a promising approach for treating inflammation and cancer.
  • The development of PI3K inhibitors is an active area of drug discovery.

Conclusions:

  • PI3K signaling pathways are crucial for cellular regulation and disease pathogenesis.
  • Targeting PI3Ks offers a viable strategy for developing novel therapeutics.
  • Further research into PI3K modulation holds significant potential for clinical applications.

More Related Videos

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...